Viewing Study NCT01965535


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-02-19 @ 2:40 PM
Study NCT ID: NCT01965535
Status: COMPLETED
Last Update Posted: 2018-11-16
First Post: 2013-10-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
Sponsor: Gilead Sciences
Organization: